|
Tabla 1: Comparación de características epidemiológicas y de laboratorio entre los pacientes con apendicitis perforada y no perforada. |
|||
|
Variable |
No perforado N = 63 n (%) |
Perforado N = 37 n (%) |
p |
|
Edad (años)* |
38.6 [1.8] |
49.9 [3.1] |
0.004§ |
|
Sexo femenino |
31 (49) |
18 (36) |
0.96 |
|
Diabetes |
1 (2) |
4 (11) |
0.04§ |
|
Hipertensión |
6 (73) |
7 (19) |
0.18 |
|
Fiebre |
14 (22) |
14 (38) |
0.09 |
|
Tiempo de evolución (horas)* |
28.4 [4.2] |
62.3 [14] |
0.003§ |
|
Leucocitos (103/uL)* |
13.4 [6.2] |
13.8 [6.9] |
0.42 |
|
Neutrófilos (103/uL)* |
79.5 [16.5] |
80 [12] |
0.46 |
|
Hemoglobina (g/dL)* |
16 [1.8]§ |
15.3 [2.7]§ |
0.03§ |
|
Bilirrubina total (mg/dL)* |
0.99 [0.62]‡ |
1.08 [0.84] |
0.31 |
|
Bilirrubina directa (mg/dL)* |
0.38 [0.24]‡ |
0.42 [0.34] |
0.09 |
|
Bilirrubina indirecta (mg/dL)* |
0.57 [0.43] |
0.57 [0.63] |
0.58 |
|
Hiperbilirrubinemia (mg/dL)** |
10 (16) |
10 (27) |
0.178‡ |
|
GGT (U/L) |
26.8 (26.5) |
35.2 (42.7) |
0.081 |
|
Sodio (mmol/L)* |
138 [3.0]§ |
136 [4.0]§ |
0.001§ |
|
Cl (mmol/L)* |
105 [3.0]§ |
102. [5.5]§ |
0.002§ |
|
Colesterol (mg/dL)* |
194 [51]§ |
168 [47]§ |
0.02§ |
|
* Mediana y rango intercuartil. ** Cifra de bilirrubina total > 1.5 mg/dL. ‡ Datos con significancia estadística. § Cifras de bilirrubina total y directa e hiperbilirrubinemia. GGT = gamma-glutamiltransferasa. Cl = cloro. |
|||